Literature DB >> 14586140

Side effects of ifosfamide.

J Klastersky1.   

Abstract

Ifosfamide is relatively well tolerated but it can be associated occasionally with life-threatening complications such as arrhythmias and heart failure, severe encephalopathy and hemorrhagic cystitis. Mesna administration can control the urothelial toxicity of ifosfamide, but it is without effect on the other complications. Other preventive measures, such as amifostine or methylene blue administration, have not yet been adequately evaluated in a sufficient number of patients. Clinicians prescribing ifosfamide, especially in high doses, should be watchful for early signs of toxicity in order to discontinue ifosfamide administration soon enough to avoid development of major toxicity. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586140     DOI: 10.1159/000073351

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  23 in total

1.  Ifosfamide induced Fanconi syndrome.

Authors:  Samantha Buttemer; Mohan Pai; Keith K Lau
Journal:  BMJ Case Rep       Date:  2011-12-20

Review 2.  A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis.

Authors:  Xavier Liem; Fred Saad; Guila Delouya
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

3.  Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.

Authors:  Diane M Calinski; Haoming Zhang; Susan Ludeman; M Eileen Dolan; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2015-05-01       Impact factor: 3.922

4.  Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.

Authors:  You-Jung Shin; Ji-Young Kim; Jei-Won Moon; Rae-Mi You; Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Cancer Res Treat       Date:  2011-12-27       Impact factor: 4.679

5.  Ifosfamide associated myoclonus-encephalopathy syndrome.

Authors:  Rodolfo Savica; Alejandro A Rabinstein; Keith A Josephs
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

Review 6.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

7.  Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.

Authors:  Antonella Brunello; Umberto Basso; Elena Rossi; Micaela Stefani; Cristina Ghiotto; Dario Marino; Gino Crivellari; Silvio Monfardini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Ifosfamide induced renal rickets.

Authors:  Arul P Lionel; Girish Chinnaswamy; Rikki R John; Sarah Mathai
Journal:  Indian J Pediatr       Date:  2013-08-04       Impact factor: 1.967

9.  Severe ifosfamide-induced neurotoxicity: a case report.

Authors:  Sara Ramos Linares; Joaquín Breña Atienza; Matilde Cháfer Rudilla; Pablo Ríos Rull; Ana Cabello Rodríguez; Javier Merino Alonso
Journal:  Pharm World Sci       Date:  2009-12-23

10.  The Effect of Acetylcysteine on Renal Function in Experimental Models of Cyclophosphamide-and Ifosfamide-Induced Cystitis.

Authors:  Lukasz Dobrek; Klaudia Nalik-Iwaniak; Kinga Fic; Zbigniew Arent
Journal:  Curr Urol       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.